Filing Details
- Accession Number:
- 0001104659-21-142468
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-22 16:02:35
- Reporting Period:
- 2021-11-18
- Accepted Time:
- 2021-11-22 16:02:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410939 | Iveric Bio Inc. | ISEE | Pharmaceutical Preparations (2834) | 208185347 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1877012 | Paul Christopher Simms | C/O Iveric Bio, Inc. Five Penn Plaza, Suite 2372 New York NY 10001 | Svp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-18 | 3,069 | $16.30 | 7,069 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
